Safety and efficacy of novel P2Y12 inhibitors in acute coronary syndrome patients undergoing percutaneous coronary intervention: One-year outcomes from the GReekAntiPlatelet Registry (GRAPE).
30 August 2016 (08:30 - 12:30)
Organised by:
Abstract
Slides
About the speaker
Hygeia Hospital, Athens (Greece)
22 More presentations in this session
Access the full session
The Event
ESC Congress 2016
30 August 2016
08:30 CET
